{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 5,
        "Importance": 7,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 7,
        "Specificity": 6,
        "Sector_Spread": 5,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "$CELG soon under $90, huge dumping coming up. went in at 99.56, got out of position today at 109",
            "Correlation": 9,
            "Sentiment": 3,
            "Importance": 5,
            "Impact": 7,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 4,
            "Specificity": 8,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Credit Suisse on $CELG Based on the big six large-cap #biotech stocks in our universe, Celgene is the cheapest stock on a …",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 5,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 9,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "JPM:\" Biotech significantly underperforms the market. JPM would recommend  $CELG and $BIIB among legacy large caps and $VR…",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 8,
            "Impact": 6,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 10,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 3
        }
    ]
}